| Stage | LYV | % of rev | ACEL | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $7.7B | 100.00% | $364M | 100.00% | LYV ×21.09 |
| Gross profit | $1.9B | 25.34% | $363M | 99.86% | ACEL +74.5pp |
| Operating income | $522M | 6.81% | $29M | 7.92% | ACEL +1.1pp |
| Pre-tax income | $519M | 6.76% | $26M | 7.10% | ACEL +0.3pp |
| Net income | $403M | 5.25% | $21M | 5.67% | ACEL +0.4pp |
| Stage | LYV | ACEL | Gap · A − B |
|---|---|---|---|
| Revenue | $7.7B100.00% | $364M100.00% | LYV ×21.09 |
| Gross profit | 25.34%$1.9B | 99.86%$363M | ACEL +74.5pp |
| Operating income | 6.81%$522M | 7.92%$29M | ACEL +1.1pp |
| Pre-tax income | 6.76%$519M | 7.10%$26M | ACEL +0.3pp |
| Net income |
| 5.25%$403M |
| 5.67%$21M |
| ACEL +0.4pp |
None
No disclosed counterparties: LYV.